Literature DB >> 6809822

B cell helper factors. II. Synergy among three helper factors in the response of T cell- and macrophage-depleted B cells.

H J Liebson, P Marrack, J Kappler.   

Abstract

The concanavalin A- (Con A) stimulated supernatant of normal spleen cells (normal Con A SN) was shown to contain a set of helper factors sufficient to allow T cell- and macrophage- (M phi) depleted murine splenic B cells to produce a plaque-forming cell response to the antigen sheep red blood cells (SRBC). The activity of normal Con A SN could be reconstituted by a mixture of three helper factor preparations. The first was the interleukin 2- (IL 2) containing Con A SN of the T cell hybridoma, FS6-14.13. The second was a normal Con A SN depleted of IL 2 by extended culture with T cell blasts from which the 30,000 to 50,000 m.w. factors were isolated (interleukin X, IL X). The third was a SN either from the M phi tumor cell line P388D1 or from normal M phi taken from Corynebacterium parvum-immune mice. The combination of all three helper factor preparations was required to equal the activity of normal Con A SN; however, the M phi SN had the least overall effect. The M phi SN and IL 2 had to be added at the initiation of the culture period for a maximal effect, but the IL X preparation was most effective when added 24 hr after the initiation of culture. These results indicate that at least three nonspecific helper factors contribute to the helper activity in normal Con A SN.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6809822

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  Involvement of gamma interferon in antibody enhancement by adjuvants.

Authors:  M J Odean; C M Frane; M Van derVieren; M A Tomai; A G Johnson
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

2.  Modulation of immunoglobulin production and cytokine mRNA expression in peripheral blood mononuclear cells by intravenous immunoglobulin.

Authors:  M Toyoda; X Zhang; A Petrosian; O A Galera; S J Wang; S C Jordan
Journal:  J Clin Immunol       Date:  1994-05       Impact factor: 8.317

Review 3.  Hairy cell leukemia: clinical features and therapeutic advances.

Authors:  B C Lembersky; H M Golomb
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

4.  Identification of a unique B-cell-stimulating factor produced by a cloned dendritic cell.

Authors:  C Clayberger; R H DeKruyff; R Fay; H Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

5.  Roles of IL-2 and antigen in the later stages of the primary antibody response.

Authors:  J Sawada; T Terao; M A Leon
Journal:  Immunology       Date:  1987-10       Impact factor: 7.397

6.  Interleukin 2 receptors on human B cells. Implications for the role of interleukin 2 in human B cell function.

Authors:  A Muraguchi; J H Kehrl; D L Longo; D J Volkman; K A Smith; A S Fauci
Journal:  J Exp Med       Date:  1985-01-01       Impact factor: 14.307

7.  The dissociation of interleukin-2 production and antigen-specific helper activity by clonal analysis.

Authors:  J R Lamb; E D Zanders; M Feldmann; P Lake; D D Eckels; J N Woody; P C Beverley
Journal:  Immunology       Date:  1983-11       Impact factor: 7.397

8.  Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia.

Authors:  S J Korsmeyer; W C Greene; J Cossman; S M Hsu; J P Jensen; L M Neckers; S L Marshall; A Bakhshi; J M Depper; W J Leonard; E S Jaffe; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

9.  Role of recombinant interleukin-1 compared to recombinant T-cell replacing factor/interleukin-5 in B-cell differentiation.

Authors:  N Koyama; N Harada; T Takahashi; S Mita; H Okamura; A Tominaga; K Takatsu
Journal:  Immunology       Date:  1988-02       Impact factor: 7.397

10.  Interleukin 1 can act as a B-cell growth and differentiation factor.

Authors:  B L Pike; G J Nossal
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.